Some experts even tentatively suggest its possible that GLP-1s could help those with a restrictive eating disorder, such as anorexia nervosa or orthorexia (an unhealthy obsession with healthy eating)
However, obesity, as assessed by body composition, has successfully predicted mortality through repeated studies, highlighting the importance of maintaining adequate muscle mass in addition to avoiding excess body fat
The IM injection is an affordable and convenient point of entry to patients who are more concerned with cellular health, immune support, or energy
The mechanism of action of berberine differs fundamentally from that of GLP-1 agonists
Alycia Halladay, chief science officer at the Autism Science Foundation, in a statement